Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $22,464 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | Q301MEDICAL- LABORATORY TESTING | Apr 28, 2026 | Apr 27, 2026 | Mar 31, 2029 | ||
| MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $1,525,625,390 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Jul 31, 2023 | Jul 31, 2023 | Jul 29, 2033 | ||
| CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM. | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $5,721,771 | DEPT OF THE ARMY | DEFENSE HEALTH AGENCY (DHA) | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN93 | Sep 26, 2019 | Sep 26, 2019 | Feb 29, 2024 | ||
| ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $804,857,151 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325414Biological Product (except Diagnostic) Manufacturing | 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | Aug 30, 2019 | Aug 30, 2019 | Aug 29, 2029 | ||
| DILUENT REPLACEMENT | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $12,229,056 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325414Biological Product (except Diagnostic) Manufacturing | 6505DRUGS AND BIOLOGICALS | Mar 13, 2019 | Mar 13, 2019 | Jun 30, 2019 | ||
| IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $73,947,282 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541711 | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Sep 15, 2017 | Sep 15, 2017 | Jul 25, 2025 | ||
| IGF::OT::IGF | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $1,433,362,669 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541711 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 30, 2016 | Sep 30, 2016 | Sep 29, 2026 | ||
| IGF::OT::IGF FOR OTHER FUNCTIONSTHIS CONTRACT IS FOR THE ADVANCED DEVELOPMENT OF NUTHRAX (ANTHRAX VACCINE ABSORBED WITH CPG 7909) OR AV7909 | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $43,794,113 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541711 | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Mar 23, 2015 | Mar 23, 2015 | Jul 31, 2019 | ||
| IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $30,177,861 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541712 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 28, 2014 | Aug 28, 2014 | Feb 29, 2024 | ||
| IGF::OT::IGF, THE FIRST ORAL ANTIBIOTIC FOR THE TREATMENT OF ACUTE MELIODOSIS AND SELECT AGENTS" FOR MODIFICATIONS P00011, 12 AND 13. | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $17,220,820 | DEFENSE THREAT REDUCTION AGENCY (DTRA) | DEFENSE THREAT REDUCTION AGENCY (DTRA) | — | 541711 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 11, 2014 | Aug 11, 2014 | Oct 10, 2019 | ||
| IGF::OT::IGF -- TASK ORDER TO EMERGENT PRODUCT DEVEOPMENT DELIVERY OF MASTER CELL BANK VIALS TO THE USG FOR THE FUTURE PRODUCTION OF ANTHRAX ANTITOXIN HHSO100201300011I | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $0 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 325412Pharmaceutical Preparation Manufacturing | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Sep 17, 2013 | Sep 17, 2013 | Sep 8, 2018 | ||
| TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087 | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $118,848,654 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541711 | C118 | Sep 17, 2010 | Sep 17, 2010 | Jun 9, 2022 | ||
| TAS::75 0885::TAS DEVELOPMENT OF TECHNOLOGIES TO FACILITATE THE USE OF, AND RESPONSE TO, BIODEFENSE VACCINES | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $41,126,573 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541711 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 31, 2010 | Aug 31, 2010 | Oct 3, 2020 | ||
| BIOMEDICAL (ADVANCED) | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $26,710,106 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541712 | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Sep 25, 2008 | Sep 25, 2008 | Jul 7, 2021 | ||
| NEW AWARD UNDER BAA NIH-NIAID-DMID-08-20. THIS IS ONE OF FOUR AWARDS UNDER THIS BAA. | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $18,105,370 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541711 | AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | Sep 1, 2008 | Sep 1, 2008 | Aug 31, 2012 | ||
| BIOMEDICAL (BASIC) | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $12,196,302 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541710 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 21, 2007 | Sep 21, 2007 | Dec 31, 2011 | ||
| 200106!000124!2100!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1701C0026 !A!N!*!N! !20010118!20010807!189488554!189488554!189488554!N!ANTEX BIOLOGICS INC !300 PROFESSIONAL DRIVE !GAITHERSBURG !MD!20879!31175!031!24!GAITHERSBURG !MONTGOMERY !MARYLAND !+000000068112!N!N!000000000000!AN95!RDTE/OTHER MEDICAL - ENG/MANUF DEVELOP !S1 !SERVICES !1000!NOT DISCERNABLE OR CLASSIFIED !541710!*!*!3! ! ! !*!*!*!B!*!*!A! !A !N!J!2!002!K! !Z!N!Z! ! !N!B!N!N! ! !A! !B!A!000!B!B!N! ! ! ! ! ! !0001! | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $0 | DEPT OF THE ARMY | — | — | 541710 | AN95 | Jan 18, 2001 | Jan 18, 2001 | — | ||
| 200106!000188!2100!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1701P0009 !A!N!*!Y! !20001003!20001202!189488554!189488554!189488554!N!ANTEX BIOLOGICS INC !300 PROFESSIONAL DRIVE !GAITHERSBURG !MD!20879!31175!031!24!GAITHERSBURG !MONTGOMERY !MARYLAND !+000000050000!N!N!000000000000!Q301!LABORATORY TESTING SERVICES !S1 !SERVICES !1000!NOT DISCERNABLE OR CLASSIFIED !541380!*!*!9! ! ! !*!*!*!C!*!*!A! !A ! !J!2!005! ! !C!N!Z! ! !Y!B!U!N! ! !A! !A!A!000!A!B!N! ! ! ! ! ! !0001! | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $0 | DEPT OF THE ARMY | — | — | 541380Testing Laboratories and Services | Q301MEDICAL- LABORATORY TESTING | Oct 3, 2000 | Oct 3, 2000 | — | ||
| 200010!2100!000745!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1799C9095 !A!*!P00004 !20000623!20011125!189488554!189488554!189488554!N!057Y1!ANTEX BIOLOGICS INC. !300 PROFESSIONAL DRIVE !GAITHERSBURG !MD!20879!31175!031!24!GAITHERSBURG !MONTGOMERY !MARYLAND !0001!+000000459600!N!N!000000000000!AN91!RDTE/OTHER MEDICAL - BASIC RESEARCH !S1 !SERVICES !1000!NOT DISCERNABLE OR CLASSIFIED !8731!3!*!*!C!B!A!*!A !N!J!2!002!K!* !Z!N!Z!* !* !N!B!N!A!*!B!A!A!A!* !*!N!C!B!N!*!*!*!*!*! | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $0 | DEPT OF THE ARMY | — | — | — | AN91 | Jun 23, 2000 | Jun 23, 2000 | — | ||
| 199712!2100!1946!AH01 !USA AVIATION AND MISSILE COMMAND!DAAH0197CR116 !A!*!* !19970513!19971210!189488554!189488554!189488554!N!057Y1!ANTEX BIOLOGICS INC !300 PROFESSIONAL DR !GAITHERSBURG !MD!20879!31175!031!24!GAITHERSBURG !MONTGOMERY !MARYLAND !0001!+000000098400!N!N!000000000000!AD92!RDTE/OTHER DEFENSE-APPLIED RESEARCH !A2 !MISSILE AND SPACE SYSTEMS !1000!NOT DISCERNABLE OR CLASSIFIED !8731!3!*!*!*!B!N!B!A !N!J!2!002!E!* !Z!W!Z!* !* !N!B!*!A!*!A!A!A!*!* !*!N!A!B!N!*!*!*!*!*! | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $0 | DEPT OF THE ARMY | — | — | — | AD92 | May 13, 1997 | May 13, 1997 | — | ||
| — | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $0 | DEPT OF THE NAVY | — | — | — | AD91 | Jul 15, 1996 | Jul 15, 1996 | Dec 15, 1996 |